Differential Rates and Clinical Significance of Periprocedural Myocardial Infarction After Stenting or Bypass Surgery for Multivessel Coronary Disease According to Various Definitions.

[1]  J. Hartikainen,et al.  Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial , 2016, The Lancet.

[2]  S. Pocock,et al.  Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. , 2016, The New England journal of medicine.

[3]  S. Ooi,et al.  Peri-procedural myocardial infarction following percutaneous coronary intervention as defined by the Universal Definition predicts increased mortality at 2 years. , 2015, International journal of cardiology.

[4]  A. Yeung,et al.  Trial of everolimus-eluting stents or bypass surgery for coronary disease. , 2015, The New England journal of medicine.

[5]  M. Mack,et al.  Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). , 2013, Journal of the American College of Cardiology.

[6]  Seung‐Jung Park,et al.  Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention. , 2013, European heart journal.

[7]  Akshay S. Desai,et al.  Strategies for multivessel revascularization in patients with diabetes. , 2012, The New England journal of medicine.

[8]  Maarten L. Simoons,et al.  The third universal definition of myocardial infarction , 2013 .

[9]  M. Pencina,et al.  Prognostic Implications of Creatine Kinase-MB Elevation After Percutaneous Coronary Intervention: Results From the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) Registry , 2011, Circulation. Cardiovascular interventions.

[10]  M. Jeong,et al.  Randomized trial of stents versus bypass surgery for left main coronary artery disease. , 2011, The New England journal of medicine.

[11]  V. Hasselblad,et al.  Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. , 2011, JAMA.

[12]  Seung‐Jung Park,et al.  Long-term comparison of drug-eluting stents and coronary artery bypass grafting for multivessel coronary revascularization: 5-year outcomes from the Asan Medical Center-Multivessel Revascularization Registry. , 2011, Journal of the American College of Cardiology.

[13]  Li Jiang.  Myocardial Infarction due to Percutaneous Coronary Intervention , 2011 .

[14]  Antonio Colombo,et al.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.

[15]  Seung‐Jung Park,et al.  Long-Term Mortality After Percutaneous Coronary Intervention With Drug-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for the Treatment of Multivessel Coronary Artery Disease , 2008, Circulation.

[16]  Fred S Apple,et al.  Universal definition of myocardial infarction. , 2007, Journal of the American College of Cardiology.

[17]  D.,et al.  Regression Models and Life-Tables , 2022 .